News for United Therapeutics Corp.

TipRanks 323d

United Therapeutics’ Tyvaso Poised for Growth: A Strong Buy Amidst Competitive Landscape

TipRanks 323d

Analysts’ Opinions Are Mixed on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), United Therapeutics (UTHR) and Exact Sciences (EXAS)

TipRanks 323d

Buy Rating Justified by United Therapeutics’ Strong Market Position and Positive Momentum in Product Performance

TipRanks 324d

United Therapeutics: Strong Sales and Strategic Positioning Merit a Buy Rating

InvestorPlace 324d

UTHR Stock Earnings: United Therapeutics Misses EPS, Beats Revenue for Q2 2024

Seeking Alpha 324d

United Therapeutics GAAP EPS of $5.85 misses by $0.55, revenue of $714.9M beats by $24.05M

Seeking Alpha 325d

United Therapeutics Q2 2024 Earnings Preview

Markets Insider Automation 325d

Here's what Wall Street expects from United Therapeutics's earnings report

InvestorPlace 329d

The 3 Best 3D Bioprinting Stocks to Buy Now

Benzinga 330d

Navigating 9 Analyst Ratings For United Therapeutics

TipRanks 337d

Wells Fargo Sticks to Its Buy Rating for United Therapeutics (UTHR)

TipRanks 337d

United Therapeutics: A Strong Buy on Robust Tyvaso Sales and Promising Market Expansion

InvestorPlace 339d

3 Biotech Stocks to Buy Now: Q3 Edition

Seeking Alpha 344d

United Therapeutics cut at Morgan Stanley on risk-reward setup

TipRanks 344d

United Therapeutics: Strong Buy on Tyvaso’s Promising IPF Treatment Prospects

Benzinga 346d

Unveiling 6 Analyst Insights On United Therapeutics

InvestorPlace 347d

3 Undervalued Stocks on Track to Double (or More) by 2028

InvestorPlace 353d

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

Seeking Alpha 356d

Catalyst Watch: Tesla deliveries, Constellation Brands earnings, and the June Jobs Report

TipRanks 358d

United Therapeutics (UTHR) Gets a Buy from Oppenheimer

TipRanks 358d

United Therapeutics Faces Growth Headwinds and Valuation Shift: Maintaining Sell Rating

InvestorPlace 364d

The 3 Best Medical Device Stocks to Buy in June 2024

Benzinga 373d

Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings)

TipRanks 373d

United Therapeutics: Poised for Growth in Pulmonary Hypertension Market, Underappreciated by the Market

InvestorPlace 380d

The 3 Most Undervalued Healthcare Stocks to Buy in June 2024

Seeking Alpha 384d

Liquidia surges after United Therapeutics request for preliminary injunction denied (update)

Benzinga 394d

Expert Ratings For United Therapeutics

InvestorPlace 396d

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

Benzinga 407d

Perrigo Q1 Earnings Surpass, Sales Miss Estimates

TipRanks 407d

Analysts Are Bullish on Top Healthcare Stocks: Olema Pharmaceuticals (OLMA), Arcus Biosciences (RCUS)

InvestorPlace 409d

3 Biotech Stocks to Double Your Money in the Next 24 Months

TipRanks 414d

Analysts Have Conflicting Sentiments on These Healthcare Companies: United Therapeutics (UTHR) and BioRestorative Therapies (BRTX)

Benzinga 414d

The Latest Analyst Ratings For United Therapeutics

TipRanks 414d

United Therapeutics (UTHR) Gets a Buy from Oppenheimer

TipRanks 414d

Buy Rating on United Therapeutics: Strong Market Position and Growth Potential Despite New Competitors

TipRanks 414d

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Moderna (MRNA) and Neurocrine (NBIX)

TipRanks 414d

Buy Rating for United Therapeutics: Strong Performance and Growth Potential Despite Competitive Pressures

InvestorPlace 415d

UTHR Stock Earnings: United Therapeutics Beats EPS, Beats Revenue for Q1 2024

Seeking Alpha 415d

United Therapeutics GAAP EPS of $6.17 beats by $0.51, revenue of $677.7M beats by $53.51M

Seeking Alpha 416d

United Therapeutics Q1 2024 Earnings Preview

Markets Insider Automation 416d

United Therapeutics earnings preview: what Wall Street is expecting

Seeking Alpha 416d

Notable earnings before Wednesday's open

Seeking Alpha 422d

Doctors perform first combined heart pump and pig kidney transplant surgery

TipRanks 423d

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Addus Homecare (ADUS)

TipRanks 423d

Wells Fargo Sticks to Their Buy Rating for United Therapeutics (UTHR)

TipRanks 428d

United Therapeutics: Strategic Expansion and Competitive Edge Reinforce Outperform Rating

Seeking Alpha 446d

United Therapeutics motion for restraining order over Liquidia's Yutrepia denied

TipRanks 448d

Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), United Therapeutics (UTHR) and Immunome (IMNM)

Seeking Alpha 448d

Liquidia gains after court win in patent dispute with United Therapeutics

Seeking Alpha 450d

Merck hits all-time high after FDA nod for lung disease therapy

	
		OSZAR »